The fact that so many people interested here are arguing

New Post Public Reply Private Reply Replies (1) Message Board
Normy
941
The fact that so many people interested here are arguing about the data and what was presented indicates how poorly the PR was written again.

It seems every time there is a PR I read it on my phone in the morning, put down my phone and ask myself "what did i just read?" Then i think "well its probably good news, but it was presented and worded so poorly that it will be spun as bad"

And I'm an investor actively aware of CYDY goings on, so i kinda know what to expect. Imagine for someone looking to invest. They would read the PR and have to analyze and process the jumbled verbiage and syntax, read between the lines, refer to other sources to fully understand the PR. Thats not much of a sales pitch or promotion. A PR should never have to be explained or clarified. It needs to stand on its own and clearly state its reason. Especially if it is good news.

I dont know if this is true as i havent seen the latest video yet, but i thought i just read a comment that the one death was due to a car wreck. It is inconceivable to me that you would add irrelevant data without explanation. Its just as bad in reverse when Covid stats include car wrecks in the covid death toll.

It seems to me that NP refuses to learn from this. It is mind boggling to me to continue to put out information that only makes logical sense to the writer of the PR. This is a pattern that is not going to stop. The fact that this is not the first PR in recent weeks to be clarified or reissued should be an embarrassment to the writer and NP (assuming they are different...)

Leronlimab is still a great drug and will eventually get there. I am just thinking this is like a running back training by dragging the little parachute behind them or running in a pool. We are still making progress and being held back by the circumstances we put ourselves in. Once we are out of the pool and on the field we will be even faster... I hope.
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Core Lab's Quarterly Grit: Navigating a Turbulent Market

Updated Category News Views 0

Core Lab's Quarter in Review With the kind of resilience that makes a trader's hands shake ever so slightly less over a coffee, Core Laboratories Inc. heads into the fourth quarter of 2026. This isn't your typical Wall Street story, that's for sure. Watching a solid player like Core navigate the bumpy roads of today's volatile market reminds me of a...

Continue Reading
Wendy's Faces Takeover Bid Amid Strategic Focus Shift

Updated Category News Views 87

Behind the Unsolicited Offer Folks, it looks like Wendy's (NASDAQ:WEN) got itself mixed up in some high-stakes shenanigans. An unsolicited, non-binding proposal slammed into them, courtesy of the Investor Group led by Trian Partners, Flynn Group LP, BlueFive Capital, and Sixth Street Partners, itching to scoop up every last piece of Wendy’s stock they ain't already...

Continue Reading
Seasonal Hiring Booms as Firms Eye Long-Term Talent

Updated Category News Views 114

A Strategic Shift in Seasonal Hiring It ain't just about the holiday rush anymore, folks. Companies are waking up to the idea that seasonal gigs are more than a temporary Band-Aid. This year, nearly 2 out of 5 companies are planning to bring more seasonal folks into the fold compared to last year. That means a good dose of them are looking for longer-term value—like...

Continue Reading
BASIS Bellevue Expands with New K-4 Campus

Updated Category News Views 65

A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...

Continue Reading
Royce Global Trust: Insights on RGT's Performance

Updated Category News Views 80

Analyzing Royce Global Trust's Approach When you dig into the Royce Global Trust portfolio, what emerges is a tapestry woven through decades of grit and determination in the investing world. This closed-end fund, trading under the symbol NYSE: RGT, is no stranger to the ebbs and flows of global markets. With every tick of the clock, speculation dances around this fund's...

Continue Reading
Raleigh's Auction Direct Stresses Oil Changes

Updated Category News Views 50

Keeping Engines Humming in Raleigh There's nothing quite like keeping an engine running like clockwork, especially in a place like Raleigh where folks rely on their rides day in and day out. That's where Auction Direct USA steps in, offering professional oil change services aimed at preserving the performance and reliability of used cars. A simple yet crucial service:...

Continue Reading
Caylent's Strategic Moves Gain Eyeballs in ISG Report

Updated Category News Views 103

Big Moves in the Contact Center Game There’s a buzz in the tech trenches, folks. Caylent just climbed onto the radar with its prominent mention in the 2026 ISG Provider Lens® Amazon Connect Ecosystem Report. Being dubbed a Product Challenger is no small feat when you’re pitted against some of the giants in tech. What’s their edge? An AI-first strategy, of course,...

Continue Reading
Long March Reflections: Lesson of Adaptation Endures

Updated Category News Views 22

Ever stood in a place where history feels so heavy you can almost touch it? That's Lazikou, a gorge in southern Gansu, where ninety years ago, young soldiers of China's Red Army faced a seemingly impassable barrier. Yet, they managed to climb, transform a military retreat into legend, and essentially shape the nation's path ahead. It's a feat that still sends ripples...

Continue Reading
OLX Rolls Out New AI Tools Amid Trust Issues

Updated Category News Views 78

A Grounded Approach to AI-Driven Market Evolution OLX Group's stepping into some turbulent waters, folks. They've dropped two new AI-assisted tools, Agentic Selling and DealFinder, while users are still trying to wrap their heads around trusting AI. Now, don't get me wrong, there's potential here—but the road ahead isn't paved with gold just yet. AI-Powered Tools Ready...

Continue Reading
TransCode Pursues Strategic Moves for TTX-MC138 Value

Updated Category News Views 56

A New Chapter for TransCode? Every once in a while, you find companies taking bold steps that make the market look twice. Today, that’s TransCode Therapeutics (NASDAQ: RNAZ) putting their chips on the table, determined to find the best route forward for their oncology efforts. Now, I’ve seen outfits talk plans without substance, but getting Tungsten Advisors on board...

Continue Reading

Top 5 Most Recently Viewed Articles

Cliquall Enhances Global Access with Language Support Update

Updated Category News Views 176

Cliquall Expands Global Access Through Multi-Language Support In an exciting development, Cliquall has unveiled its multi-language website and customer support system, aimed at enhancing accessibility and inclusivity for traders around the world. This innovative update now supports languages including Simplified Chinese, Traditional Chinese, Japanese, Korean, and English,...

Continue Reading
Understanding Riksbank's Auction Process for Government Bonds

Updated Category News Views 233

Riksbank's Auction Process for Government Bonds The Riksbank, Sweden's central bank, plays a crucial role in managing the country's monetary policy and influences the national economy. One of the key aspects of its operations is the auctioning of government bonds. This process is designed to facilitate the financing of government activities and provide crucial liquidity...

Continue Reading
Sony's IMX742: Revolutionizing Endoscopic Imaging

Updated Category News Views 60

Sony's Bold Move into Medical Tech You wouldn't expect a company like Sony to make waves in the medical field, but there they go again, shaking things up with their latest announcement. Lurking past the shiny consumer electronics, they've got the IMX742, a sensor designed for single-use endoscopes. A humble 1 mm square powerhouse, boasting about 0.51 megapixels of digital...

Continue Reading
Investigating Key Mergers: ACA, APGE, BOLD, GBCS

Updated Category News Views 7

Probing the Potential Pitfalls of Corporate Mergers Well, here's a situation where the lawyers are having a field day. Monteverde & Associates, perched up in the Empire State Building of all places, is nudging investors with a firm elbow as they dig into a quartet of mergers that involve Arcosa, Apogee Therapeutics, Boundless Bio, and Selectis Health. When legal eagles...

Continue Reading
Market Trends: Analyzing Recent Momo Stock Movements and Nvidia

Updated Category News Views 512

Understanding Recent Momo Stock Movements In today's dynamic market, it's crucial to grasp the ongoing trends that could significantly impact investing. Recently, a noticeable sell-off in momo stocks has taken place, influenced by an interplay of expectations and reality. Investors are encouraged to sharpen their focus on these movements and understand their implications....

Continue Reading